Rescue Medication

Rescue Medication refers to a drug used to provide immediate relief of acute symptoms or breakthrough events during ongoing treatment, rather than serving as the primary long-term therapy. Rescue medications are common in asthma, pain management, migraine, allergy, epilepsy, and oncology supportive care, where rapid symptom control prevents complications and improves patient comfort. These medicines are typically fast-acting and used as needed based on symptom severity.

In clinical trials, rescue medication use is carefully defined in protocols because it can influence efficacy assessments and confound interpretation of investigational treatment benefit. For example, frequent rescue medication use may indicate inadequate control by the study drug, while restricted rescue access may raise ethical concerns if patients experience unmanaged symptoms. Trial endpoints sometimes incorporate rescue medication frequency as secondary outcomes reflecting real-world clinical utility. The pharmaceutical industry also designs formulations optimised for rescue use, such as inhalers, nasal sprays, sublingual tablets, or injectable autoinjectors enabling rapid onset and convenient administration. Regulatory review considers whether rescue medication requirements affect overall benefit-risk assessment and patient quality of life. Rescue medication bridges symptom management and long-term disease control across diverse therapeutic areas.